Cardiac conduction defects and complete heart block in myotonic dystrophy

  • Sandeep Khanna a. Department of Cardiothoracic Anesthesiology, Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, Ohio. b. Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, Ohio. c. Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Sergio Bustamante Department of Cardiothoracic Anesthesiology, Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, Ohio

References

1. Russell SH, Hirsch NP. Anaesthesia and myotonia. Br J Anaesth1994;72:210–216.
2. Kusumoto FM, Schoenfeld MH, Barrett C, et al. ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2019;140:e382–e482.
3. Zaballos M, Jimeno C, Almendral J, et al. Cardiac electrophysiological effects of remifentanil: study in a closed-chest porcine model. Br J Anaesth 2009;103:191–198.
How to Cite
1.
Khanna S, Bustamante S. Cardiac conduction defects and complete heart block in myotonic dystrophy. Colomb. j. anesthesiol. [Internet]. 2020Jul.1 [cited 2020Sep.25];48(3):162-3. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/911

Downloads

Download data is not yet available.
Published
2020-07-01
How to Cite
1.
Khanna S, Bustamante S. Cardiac conduction defects and complete heart block in myotonic dystrophy. Colomb. j. anesthesiol. [Internet]. 2020Jul.1 [cited 2020Sep.25];48(3):162-3. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/911
Section
Images